Experience
Dr Evan Papanastasiou | MD MSc PhD MBA
Pharmaceutical Physician, Clinical Neuroscientist and Psychiatrist with professional experience in the pharmaceutical industry (sponsor, CRO and SMO level), academia & health sector.
Pharmaceutical Experience
CNS & other therapeutic areas
VicePresident Clinical Development at HMNC Brain Health 2023 to present. Responsible for the strategy, direction, and execution of the Company’s clinical development plans, such as progressing HMNC Brain Health’s Ketabon program towards the pathway of commercialization.
Global Clinical Program Leader at Boehringer Ingelheim 2020 to 2023. Global clinical leadership for early and novel CNS products, responsible for strategy, execution and ongoing refinement of clinical development pathways; coordination of scientific & cross-functional teams in a matrix environment. Based at HQs in Ingelheim, Germany.
Senior Global Medical Advisor at Lundbeck 2018 to 2019. Support for one marketed product and several pipeline compounds in schizophrenia; scientific communication and evidence generation strategies; publication plans; advisory boards, conferences; disease and product training; support for the affiliate offices; review of promotional material, regulatory and clinical documents. Based at HQs in Copenhagen, Denmark.
Senior Clinical Research Physician at Europital 2017. Medical consultancy and overview of medical monitoring for phase II clinical trials; focus on psoriatic arthritis, ankylosing spondylitis and SLE; review of regulatory and clinical documents. Based at HQs in Ghent, Belgium.
Clinical Research Physician at Mundipharma Research 2016. Support for two regulatory submissions in the field of addiction therapy (in preparation of the final dossier) and evaluation of multiple in-licensing opportunities in CNS / addiction in due diligence teams; contribution to the company’s strategy for cognition-based treatments; review of regulatory and clinical documents. Based at HQs in Cambridge, England.
Clinical Research Physician at MAC Clinical Research 2015 to 2016. Investigator for several phase III clinical trials with focus on osteoarthritis, fibromyalgia, atopic dermatitis, psoriasis & Alzheimer’s; providing medical supervision & achieving high rates of patients’ enrolment and retention. Based at Leeds Memory Clinic, England.
Clinical Experience
Psychiatry practiced at NHS teaching hospitals in London
Specialist Registrar in Psychiatry in London NHS hospitals, 2013 to 2015. General Adult, Forensic, Rehabilitation and Early Intervention Psychiatry placements, in several London Mental Health Trusts, including Camden and Islington NHS Foundation Trust, East London NHS Foundation Trust, South West London and St George's NHS Trust, South London and the Maudsley NHS Foundation Trust.
Resident in Psychiatry at Charing Cross Rotation in London, 2004 to 2008. Training organised in association with Imperial College London. General Adult, Old Age and Child & Adolescent Psychiatry placements, in several London Mental Health Trusts, including West London NHS Trust & Central and North West London NHS Foundation Trust.
Academic Experience
Schizophrenia, fMRI, cognition & psychosis
Clinical Investigator at King’s College London 2009 to 2013. Medical cover for a multi-center RCT, testing a health promoting intervention in chronically ill psychotic patients; primary physician for a phase III pharmaceutical clinical trial in schizophrenia; manager of the site, overseeing performance and coordinating team members.
EDUCATION
MD, MSc, PhD, MBA, Executive Programs
Executive Education at Harvard Medical School 2021 to 2022. The Accelerate Executive Program is delivered by HMS to empower pharmaceutical professionals to grow as leaders.
Business Studies / MBA at the American College of Thessaloniki 2019 to 2021. Thesis: Investigation of investors’ trading responses to pharmaceutical announcements of interest.
Doctoral Studies in Psychosis / PhD at King’s College London 2012 to 2018. Thesis: Investigation of the neural basis of the prodromal manifestations of psychosis, employing fMRI and neurocognitive testing.
Cognitive Neuropsychology Studies / MSc at Birkbeck College 2007 to 2008. Thesis: Investigation of the selective loss of native language vocabulary following learning of a second language.
Medical Studies / MD at the Aristotle University of Thessaloniki 1992 to 1998. Extracurricular volunteering for the local branch of Médecins Sans Frontières.
Testimonials
“Evan has been supporting a large number of in-licensing projects as well as disease area strategy development at Mundipharma Research. He demonstrates a real collaborative spirit in cross-functional teams and models excellent team working as well as leadership skills. Evan is always keen to learn and take on new challenges.”
“Evan has been working as Senior Medical Advisor in 2 different teams at Lundbeck for 1 year. In my team, he was involved in a project in early development. To highlight specific activities: Evan contributed to strategic discussions related to phase 1 study, he organized a global advisory board and he conducted multiple literature searches to support pipeline projects. I would like to highlight his skills to produce rapidly high-quality overviews based on literature searches. It meant that I could trust Evan to deliver both quality and on time. Besides Evan was a very nice person to collaborate with.”
“Evan reported to me between 2011-2013; during that period he successfully led a pharma-funded phase 3 trial in Schizophrenia, both as an investigator and a manager. He applied excellent clinical judgement and assertive leadership in resolving the multitude of issues that usually arise in those multifaceted trials. He also completed his PhD at the IoPPN under my supervision and has published this highly cited research in several high impact journals. I would recommend him wholeheartedly to any organisation.”